Skip to main content
MarketStoryBook

H. Lundbeck A/S in 1 story

The narratives HLUN-B.CO currently appears in, with its side and exposure in each.

Bull side

0 stories

No bull-side stories for HLUN-B.CO yet.

Bear side

1 story
  • America Imports the World's Drug Prices

    HLUN-B.CO in “America Imports the World's Drug Prices”

    StableExposure: not rated yet

    US reference pricing puts global blockbuster economics—and not just American list prices—under pressure.

    Lundbeck's patented neuroscience portfolio depends on premium developed-market pricing that could be undermined by linking US reimbursement to lower foreign prices.